Neurocognitive battery feasible in 3-year-olds during leukemia treatment

by Elana GotkineA brief neurocognitive battery is feasible for use in 3-year-olds during acute lymphoblastic leukemia treatment, according to a studypublishedonline Dec. 9 inPediatri

Updated on: January 22,2025 0

Neurocognitive battery feasible in 3-year-olds during leukemia treatment

by Elana GotkineA brief neurocognitive battery is feasible for use in 3-year-olds during acute lymphoblastic leukemia treatment, according to a studypublishedonline Dec. 9 inPediatri

Updated on:January 22,2025 0

Japan study finds decline in breast cancer screening participation rates during the COVID-19 pandemic

Updated on: March 25,2025 0

Japan study finds decline in breast cancer screening participation rates during the COVID-19 pandemic

Updated on:March 25,2025 0

Low-dose plasma treatment shows promise for slowing down tumor growth

by Nie Lili and Zhao Weiwei,Chinese Academy of SciencesUnder the influence of electrodes, low-temperature plasma emits a purple glow in the laboratory. Credit: Nie LiliA recent study has shown t

Updated on: January 23,2025 0

Low-dose plasma treatment shows promise for slowing down tumor growth

by Nie Lili and Zhao Weiwei,Chinese Academy of SciencesUnder the influence of electrodes, low-temperature plasma emits a purple glow in the laboratory. Credit: Nie LiliA recent study has shown t

Updated on:January 23,2025 0

Adding SBRT to systemic therapy could boost outcomes for some locally advanced hepatocellular carcinoma patients

Adding SBRT to systemic therapy could boost outcomes for some locally advanced hepatocellular carcinoma patientsby NRG OncologyCredit: Pixabay/CC0 Public DomainRecent results from the Phase III NRG-RT

Updated on: January 21,2025 0

Adding SBRT to systemic therapy could boost outcomes for some locally advanced hepatocellular carcinoma patients

Adding SBRT to systemic therapy could boost outcomes for some locally advanced hepatocellular carcinoma patientsby NRG OncologyCredit: Pixabay/CC0 Public DomainRecent results from the Phase III NRG-RT

Updated on:January 21,2025 0

Immunosuppression study helps understand why some prostate cancer treatments do not work as expected

byTampere UniversityOn the left is a tissue sample from the prostate stained with hematoxylin and eosin. Hematoxylin stains the nuclei blue or purple because it binds to DNA, and eosin stains th

Updated on: December 21,2024 0

Immunosuppression study helps understand why some prostate cancer treatments do not work as expected

byTampere UniversityOn the left is a tissue sample from the prostate stained with hematoxylin and eosin. Hematoxylin stains the nuclei blue or purple because it binds to DNA, and eosin stains th

Updated on:December 21,2024 0

Tailored cancer treatment: Research predicts which patients benefit from immunotherapy

byFree University of BrusselsThe99mTechnetium-labeled anti-CD163 immunotracer shows specific in vivo binding to CD163+cells. (A and B) Representative μSPECT/CT images (3D MIP) of CD1

Updated on: January 22,2025 0

Tailored cancer treatment: Research predicts which patients benefit from immunotherapy

byFree University of BrusselsThe99mTechnetium-labeled anti-CD163 immunotracer shows specific in vivo binding to CD163+cells. (A and B) Representative μSPECT/CT images (3D MIP) of CD1

Updated on:January 22,2025 0

Cancer risk declines in old age: New research helps explain why

by Ian Demsky,Memorial Sloan Kettering Cancer CenterAged AT2 cells exhibit reduced cell-intrinsic potential for regeneration and tumorigenesis. Credit:Nature(2024). DOI: 10.1038/s415

Updated on: December 21,2024 0

Cancer risk declines in old age: New research helps explain why

by Ian Demsky,Memorial Sloan Kettering Cancer CenterAged AT2 cells exhibit reduced cell-intrinsic potential for regeneration and tumorigenesis. Credit:Nature(2024). DOI: 10.1038/s415

Updated on:December 21,2024 0

Lung cancer cells can go 'off grid' and develop their own electrical network within the tumor, study shows

Updated on: March 27,2025 0

Lung cancer cells can go 'off grid' and develop their own electrical network within the tumor, study shows

Updated on:March 27,2025 0

Putting the brakes on prostate cancer cells: Androgen receptor can alter normal prostate growth

by Alan Dove,Cornell UniversityA clump of prostate cancer cells. The blue-green cells are growing, whereas the pink ones are dying by programmed cell death (apoptosis). Credit: Dave McCarthy and

Updated on: January 23,2025 0

Putting the brakes on prostate cancer cells: Androgen receptor can alter normal prostate growth

by Alan Dove,Cornell UniversityA clump of prostate cancer cells. The blue-green cells are growing, whereas the pink ones are dying by programmed cell death (apoptosis). Credit: Dave McCarthy and

Updated on:January 23,2025 0

Anticancer drugs could make immunotherapies more effective

byWeill Cornell Medical CollegePretreatment with EZH2 inhibitor (top right) leads to higher recruitment of CAR-T cells (red) into the lymph node tumor compared with control (top left). Pretreatm

Updated on: December 21,2024 0

Anticancer drugs could make immunotherapies more effective

byWeill Cornell Medical CollegePretreatment with EZH2 inhibitor (top right) leads to higher recruitment of CAR-T cells (red) into the lymph node tumor compared with control (top left). Pretreatm

Updated on:December 21,2024 0

MAGE-A4 protein promotes tumor progression by suppressing immune responses, mouse study finds

Updated on: March 27,2025 0

MAGE-A4 protein promotes tumor progression by suppressing immune responses, mouse study finds

Updated on:March 27,2025 0

Cancer diagnoses and deaths are declining in Appalachia but remain significantly higher compared to other US regions

Updated on: March 27,2025 0

Cancer diagnoses and deaths are declining in Appalachia but remain significantly higher compared to other US regions

Updated on:March 27,2025 0